India to Sri Lanka: Clindamycin Export Trade Route

The India to Sri Lanka Clindamycin corridor is one of India's established pharmaceutical export routes, with 69 shipments documented worth a combined $1.4M USD. The route is dominated by CENTURION HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.

Across 17 active suppliers, the average shipment value stands at $20.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 17.4%, placing it at rank #19 among India's top clindamycin export destinations globally.

On the import side, key buyers of Indian clindamycin in Sri Lanka include TO THE ORDER OF, STATE PHARMACEUTICALS CORPORATION , To The Order and 25 others. TO THE ORDER OF is the single largest importer with 2 shipments valued at $328.5K USD.

India's clindamycin exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. CENTURION HEALTHCARE PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CENTURION HEALTHCARE PRIVATE LIMITED, FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED , FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED — together account for 69% of total trade value on this route. The average shipment value of $20.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical finished formulation clindabact 150 clindamycin injection bp 150mg ml 10 x 2 ml ampoules e sri lanka and harmless medicines for human consumption clindamycin injection bp 300mg 2ml 10x 2 ml amp, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 2 shipments worth $328.5K USD — representing 24% of all clindamycin imports from India on this route. A total of 28 buyers are active on this corridor.